Clinical Trial Update: Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating accelerated immunization to induce cytomegalovirus immunity in stem cell donors; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV Immunization (accelerated protocol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cytomegalovirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-07-08